Christie J. Lau

Plasma HPV cell-free DNA monitoring in advanced HPV-associated oropharyngeal cancer

Glenn J. Hanna, Julianna Supplee, Yanan Kuang et al. · Annals of Oncology · 2018 · 152 citations · Full text

Medicine, Oncology, Molecular Diagnostics +16

Immuno-PET identifies the myeloid compartment as a key contributor to the outcome of the antitumor response under PD-1 blockade

Mohammad Rashidian, Martin W. LaFleur, Vincent L. Verschoor et al. · Proceedings of the National Academy of Sciences · 2019 · 132 citations · Full text

Medicine, Immunology, Oncology +17

Effect of Erlotinib Plus Bevacizumab vs Erlotinib Alone on Progression-Free Survival in Patients With Advanced<i>EGFR</i>-Mutant Non–Small Cell Lung Cancer

Thomas E. Stinchcombe, Pasi A. Jänne, Xiaofei Wang et al. · JAMA Oncology · 2019 · 124 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

EGFR-Mutated Lung Cancers Resistant to Osimertinib through EGFR C797S Respond to First-Generation Reversible EGFR Inhibitors but Eventually Acquire EGFR T790M/C797S in Preclinical Models and Clinical Samples

Deepa Rangachari, Ciric To, Jason Shpilsky et al. · Journal of Thoracic Oncology · 2019 · 92 citations · Full text

Medicine, Oncology, Pharmacology +15

Dynamic single-cell RNA sequencing identifies immunotherapy persister cells following PD-1 blockade

Kartik Sehgal, Andrew Portell, Elena V. Ivanova et al. · Journal of Clinical Investigation · 2020 · 73 citations · Full text

Life Sciences, Immunology, Oncology +17